PUNE, India -
June 8, 2021 -
PRLog -- The global lab-on-a-chip (LOC) market size is expected to reach USD 12.85 Billion at a steady CAGR of 10.6% in 2028, according to latest analysis by Emergen Research. Lab-on-a-chip market revenue growth is being steadily driven by increase in demand for point of care testing, rising prevalence of chronic diseases, and growing application of genomics and proteomics in cancer research. Proteomics is widely adopted for drug discoveries and biomarker. Rise in demand for personalized medicines is further driving Lab-on-a-chip market revenue growth, and the trend is expected to continue going ahead.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/
industry-report/
lab-on-a-chip-
market
Emergen Research has segmented the global lab-on-a-chip (LOC) market on the basis of product type, technology, application, end-use, and region:
- Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Software
- Reagents & Consumables
- Instruments
- Technology Outlook (Revenue, USD Billion; 2018–2028)
- Application Outlook (Revenue, USD Billion; 2018–2028)
- Proteomics
- Genomics
- Drug Discovery
- Diagnostics
- End-use Outlook (Revenue, USD Billion; 2018–2028)
- Diagnostic Labs
- Hospitals
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- BENELUX
- Switzerland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Rest Of MEA